发明名称 Derivado uracila ou timina para tratar hepatite c
摘要 <p>This invention relates to: (a) compounds and salts thereof that, inter alia , inhibit HCV; (b) intermediates useful for the preparation of such compounds and salts; (c) compositions comprising such compounds and salts; (d) methods for preparing such intermediates, compounds, salts, and compositions; and (e) use of such compounds, salts, and compositions.</p>
申请公布号 BRPI0816994(A2) 申请公布日期 2015.03.24
申请号 BR2008PI16994 申请日期 2008.09.17
申请人 ABBOTT LABORATORIES 发明人 WAGNER ROLF;MICHAEL D. TUFANO;KENT D. STEWART;TODD W. ROCKWAY;JOHN T. RANDOLPH;JOHN K. PRATT;CHRISTOPHER E. MOTTER;CLARENCE J. MARING;KENTON L. LONGENECKER;YAYA LIU;DACHUN LIU;ALLAN C. KRUEGER;WARREN M. KATI;DOUGLAS K. HUTCHINSON;PEGGY P. HUANG;CHARLES A. FLENTGE;PAMELA L. DONNER;DAVID A. DEGOEY;DAVID A. BETEBENNER;DAVID M. BARNES;SHUANG CHEN;THADDEUS S. FRANCZYK;YI GAO;ANTHONY R. HAIGHT;JOHN E. HENGEVELD;RODGER F. HENRY;BRIAN J. KOTECKI;XIAOCHUN LOU;KATHY SARRIS;GEOFF G.Z. ZHANG
分类号 C07D239/22;A61K31/513;A61P31/12;C07D239/54;C07D401/10;C07D403/10;C07D409/10;C07D413/10;C07D417/10 主分类号 C07D239/22
代理机构 代理人
主权项
地址